Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Is DaVita Stock Underperforming the Dow?

With a market cap of $8.6 billion, DaVita Inc. (DVA) is a leading provider of kidney dialysis services for patients with chronic kidney failure in the United States. The company operates a nationwide network of outpatient dialysis centers, offering outpatient, inpatient, and home-based hemodialysis services along with related laboratory testing for ESRD patients. 

Companies valued less than $10 billion are generally considered "mid-cap" stocks, and DaVita fits this criterion perfectly. In addition to dialysis care, DaVita provides integrated care and disease management programs, physician services, clinical research, and comprehensive kidney care solutions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.